Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • ABOUT THE IPILOGUE
    • BLOG
      • Announcements
      • Artificial Intelligence
      • Copyright
      • Innovation
      • IP Innovation Clinic
      • IP Intensive
      • Patents
      • Privacy
      • Technology
      • Trademarks
    • IPILOGUE TEAM
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
    • WRITE FOR US
  • IP INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • THE IP LUNCH CLUB
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • CONTESTS & COMPETITIONS
    • 2021 Oxford International Intellectual Property Law Moot
    • IP WRITING CHALLENGE
    Home
    >
    Myriad Genetics

    Tag: Myriad Genetics

    October 19, 2015in Cross Border Issues, Innovation, IP, Patent Practice, Patentability, Patents, US0by Editor
    1104

    The View Ahead for Software Patent Applications: USPTO Releases Update to Guidance on Patent Subject Matter Eligibility

    This article is cross-posted with permission from Bereskin & Parr. The United States Patent and Trademarks Office (USPTO) has released an updated set of Eligibility Examination Guidelines to provide guidance…

    Read more
    August 14, 2013in Canada, Infringement, IP, Patentability, Patents, Pharmaceutical Drugs, Tech Transfer, US, US-Canada Relations0by Editor
    1194

    SickKids in Court - Are Public-Private Research Collaborations a Hindrance or a Driver of the Innovative Process?

    A recent lawsuit filed by Myriad Genetics involving the alleged infringement of their controversial breast cancer screening tool has included the prestigious Toronto SickKids hospital as a co-plaintiff. This lawsuit…

    Read more
    March 8, 2013in Access to Medicines, Competition, Human Rights, IP, Patent Practice, Patentability, Patents1by Editor
    986

    The ‘Myriad’ with the Golden ‘Gene’: Australia Upholds Breast Cancer Gene Patents

    The Myriad Genetics gene patenting saga has officially shaped international jurisprudence, with the Federal Court of Australia upholding the patents for BRCA1 and BRCA2. In Cancer Voices Australia v. Myriad…

    Read more
    January 10, 2013in Blogs, Commercialization, Competition, European Union, Human Rights, Innovation, Patent Practice, Patentability, Patents, Regulatory Policy, Trade Secrets, US2by Editor
    3405

    Live and Let Die: Gene Patenting Plot Thickens as the Patent/Trade Secret Line is Blurred

    The long battle in the American courts over Myriad Genetics’ patents of BRCA1 and BRCA2, the primary diagnostic genes for hereditary breast and ovarian cancer has been well-documented in the…

    Read more
    January 9, 2013in Access to Medicines, Patentability, Patents, US1by Editor
    3092

    Staying Abreast of an Isolating Issue: USSC to Rule on Patentability of Human Genes

    On November 30, 2012 the US Supreme Court agreed to hear the appeal in the case of Association for Molecular Pathology v Myriad Genetics Inc. In particular, the Court limited…

    Read more
    July 2, 2012in Commercialization, Competition, Innovation, IP, Patentability, Patents, US0by Editor
    801

    The Patentability of Gene Sequences: Myriad Genetics’ Day in the United States Supreme Court

    In late March, The United States Supreme Court ordered the U.S Court of Appeal for the Federal Circuit to reconsider Myriad Genetics’ existing patent on two genes associated with a…

    Read more

    Posts navigation

    1 2
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736